Two addresses bought 2.15 billion PUMP worth $3.87 million in the past 16 hours

Analyst: DeepSeek's new AI model, if competitive, could cause turbulence for Nasdaq AI-related stocks

Cadrenal Therapeutics Inc recently received approval from the U.S. Food and Drug Administration (FDA) to hold an end-of-Phase II clinical trial meeting.

Larimar Therapeutics shares surged 35.6% in pre-market trading after the company announced that its treatment for a neurological disease had received “Breakthrough Therapy” designation from the U.S. Food and Drug Administration (FDA).

Phillips Edison Grocery Center Operating Partnership I, L.P. has filed documents with the U.S. Securities and Exchange Commission to apply for the issuance of senior notes.